Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Varga

Showing results (251-260 of 297) with videos related to

Pageof 30
Sort By:
Nature Communications|October 26, 2022
Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organsWenxia Wang, Swarna Bale, Jun Wei, et al.
Disability and Rehabilitation|January 28, 2023
A qualitative interview study exploring the psychological health impacts of the SPIN-CHAT program among people with systemic sclerosis at the onset of COVID-19: perceptions of trial participants and research team membersAmanda Wurz, Delaney Duchek, Kelsey Ellis, et al.
Seminars in Arthritis and Rheumatism|April 9, 2014
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort studyVivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Arthritis and Rheumatism|February 5, 2005
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung StudyDinesh Khanna, Philip J Clements, Daniel E Furst, et al.
The Journal of Investigative Dermatology|September 18, 2022
Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives FibrosisPaulene Sapao, Elisha D O Roberson, Bo Shi, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
The European Respiratory Journal|May 15, 2025
cGAS Expression is enhanced in systemic sclerosis associated interstitial lung disease and stimulates inflammatory myofibroblast activationSheeline Yu, Buqu Hu, Ying Sun, et al.
Nature Reviews. Rheumatology|February 14, 2025
An international perspective on the future of systemic sclerosis researchDavid J Abraham, Carol M Black, Christopher P Denton, et al.
Annals of the Rheumatic Diseases|July 17, 2024
Racial variability in immune responses only partially explains differential systemic sclerosis disease severityKamini E Kuchinad, Ji Soo Kim, Adrianne Woods, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
cGAS Expression is Enhanced in Systemic Sclerosis Associated Interstitial Lung Disease and Stimulates Inflammatory Myofibroblast ActivationSheeline Yu, Buqu Hu, Ying Sun, et al.
Pageof 30

Showing results (251-260 of 297) with videos related to

Sort By:
Pageof 30
Nature Communications|October 26, 2022
Fibroblast A20 governs fibrosis susceptibility and its repression by DREAM promotes fibrosis in multiple organsWenxia Wang, Swarna Bale, Jun Wei, et al.
Disability and Rehabilitation|January 28, 2023
A qualitative interview study exploring the psychological health impacts of the SPIN-CHAT program among people with systemic sclerosis at the onset of COVID-19: perceptions of trial participants and research team membersAmanda Wurz, Delaney Duchek, Kelsey Ellis, et al.
Seminars in Arthritis and Rheumatism|April 9, 2014
Development of pulmonary hypertension in a high-risk population with systemic sclerosis in the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma (PHAROS) cohort studyVivien M Hsu, Lorinda Chung, Laura K Hummers, et al.
Arthritis and Rheumatism|February 5, 2005
Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung StudyDinesh Khanna, Philip J Clements, Daniel E Furst, et al.
The Journal of Investigative Dermatology|September 18, 2022
Reduced SPAG17 Expression in Systemic Sclerosis Triggers Myofibroblast Transition and Drives FibrosisPaulene Sapao, Elisha D O Roberson, Bo Shi, et al.
The Journal of Rheumatology|October 13, 2009
Measures of response in clinical trials of systemic sclerosis: the Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS)Dinesh Khanna, Oliver Distler, Jerome Avouac, et al.
The European Respiratory Journal|May 15, 2025
cGAS Expression is enhanced in systemic sclerosis associated interstitial lung disease and stimulates inflammatory myofibroblast activationSheeline Yu, Buqu Hu, Ying Sun, et al.
Nature Reviews. Rheumatology|February 14, 2025
An international perspective on the future of systemic sclerosis researchDavid J Abraham, Carol M Black, Christopher P Denton, et al.
Annals of the Rheumatic Diseases|July 17, 2024
Racial variability in immune responses only partially explains differential systemic sclerosis disease severityKamini E Kuchinad, Ji Soo Kim, Adrianne Woods, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2024
cGAS Expression is Enhanced in Systemic Sclerosis Associated Interstitial Lung Disease and Stimulates Inflammatory Myofibroblast ActivationSheeline Yu, Buqu Hu, Ying Sun, et al.
Pageof 30